Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The pathogenesis of dermatomyositis.
Thompson C, Piguet V, Choy E. Thompson C, et al. Br J Dermatol. 2018 Dec;179(6):1256-1262. doi: 10.1111/bjd.15607. Epub 2017 May 24. Br J Dermatol. 2018. PMID: 28542733 Review.
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, Nerviani A, Giorli G, Mahto A, Montecucco C, Lauwerys B, Ng N, Ho P, Bombardieri M, Romão VC, Verschueren P, Kelly S, Sainaghi PP, Gendi N, Dasgupta B, Cauli A, Reynolds P, Cañete JD, Moots R, Taylor PC, Edwards CJ, Isaacs J, Sasieni P, Choy E, Pitzalis C; R4RA collaborative group. Humby F, et al. Lancet. 2021 Jan 23;397(10271):305-317. doi: 10.1016/S0140-6736(20)32341-2. Lancet. 2021. PMID: 33485455 Free PMC article. Clinical Trial.
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.
Rivellese F, Surace AEA, Goldmann K, Sciacca E, Çubuk C, Giorli G, John CR, Nerviani A, Fossati-Jimack L, Thorborn G, Ahmed M, Prediletto E, Church SE, Hudson BM, Warren SE, McKeigue PM, Humby F, Bombardieri M, Barnes MR, Lewis MJ, Pitzalis C; R4RA collaborative group. Rivellese F, et al. Nat Med. 2022 Jun;28(6):1256-1268. doi: 10.1038/s41591-022-01789-0. Epub 2022 May 19. Nat Med. 2022. PMID: 35589854 Free PMC article. Clinical Trial.
Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study.
Eccles JA, Thompson B, Themelis K, Amato ML, Stocks R, Pound A, Jones AM, Cipinova Z, Shah-Goodwin L, Timeyin J, Thompson CR, Batty T, Harrison NA, Critchley HD, Davies KA. Eccles JA, et al. Among authors: thompson cr, thompson b. Clin Med (Lond). 2021 Jan;21(1):53-58. doi: 10.7861/clinmed.2020-0743. Clin Med (Lond). 2021. PMID: 33479068 Free PMC article.
Functional mechanism study of the allelochemical myrigalone A identifies a group of ultrapotent inhibitors of ethylene biosynthesis in plants.
Heslop-Harrison G, Nakabayashi K, Espinosa-Ruiz A, Robertson F, Baines R, Thompson CRL, Hermann K, Alabadí D, Leubner-Metzger G, Williams RSB. Heslop-Harrison G, et al. Among authors: thompson crl. Plant Commun. 2024 Mar 7:100846. doi: 10.1016/j.xplc.2024.100846. Online ahead of print. Plant Commun. 2024. PMID: 38460510 Free article.
An observation-based, reduced-form model for oxidation in the remote marine troposphere.
Baublitz CB, Fiore AM, Ludwig SM, Nicely JM, Wolfe GM, Murray LT, Commane R, Prather MJ, Anderson DC, Correa G, Duncan BN, Follette-Cook M, Westervelt DM, Bourgeois I, Brune WH, Bui TP, DiGangi JP, Diskin GS, Hall SR, McKain K, Miller DO, Peischl J, Thames AB, Thompson CR, Ullmann K, Wofsy SC. Baublitz CB, et al. Among authors: thompson cr. Proc Natl Acad Sci U S A. 2023 Aug 22;120(34):e2209735120. doi: 10.1073/pnas.2209735120. Epub 2023 Aug 14. Proc Natl Acad Sci U S A. 2023. PMID: 37579162 Free PMC article.
279 results